Characteristics of Emergence of Mutants Resistant to Nalidixic Acid and Novobiocin in E. coli Strains with recA and lexA Mutations

2018 ◽  
Vol 33 (1) ◽  
pp. 30-33 ◽  
Author(s):  
I. N. Bodoev ◽  
E. N. Ilina ◽  
G. B. Smirnov
Keyword(s):  
Nalidixic Acid ◽  
E Coli

scholarly journals Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Amit Gaurav ◽  
Varsha Gupta ◽  
Sandeep K. Shrivastava ◽  
Ranjana Pathania
Keyword(s):  
Escherichia Coli ◽  
Acinetobacter Baumannii ◽  
Nalidixic Acid ◽  
Bacterial Infections ◽  
Clinical Isolates ◽  
Hospital Environment ◽  
Infection Model ◽  
Drug Resistant ◽  
E Coli

AbstractThe increasing prevalence of antimicrobial resistance has become a global health problem. Acinetobacter baumannii is an important nosocomial pathogen due to its capacity to persist in the hospital environment. It has a high mortality rate and few treatment options. Antibiotic combinations can help to fight multi-drug resistant (MDR) bacterial infections, but they are rarely used in the clinics and mostly unexplored. The interaction between bacteriostatic and bactericidal antibiotics are mostly reported as antagonism based on the results obtained in the susceptible model laboratory strain Escherichia coli. However, in the present study, we report a synergistic interaction between nalidixic acid and tetracycline against clinical multi-drug resistant A. baumannii and E. coli. Here we provide mechanistic insight into this dichotomy. The synergistic combination was studied by checkerboard assay and time-kill curve analysis. We also elucidate the mechanism behind this synergy using several techniques such as fluorescence spectroscopy, flow cytometry, fluorescence microscopy, morphometric analysis, and real-time polymerase chain reaction. Nalidixic acid and tetracycline combination displayed synergy against most of the MDR clinical isolates of A. baumannii and E. coli but not against susceptible isolates. Finally, we demonstrate that this combination is also effective in vivo in an A. baumannii/Caenorhabditis elegans infection model (p < 0.001)

scholarly journals In Vitro Antimicrobial Sensitivity of Escherichia coli Isolated from Clinical Sources

1970 ◽  
Vol 34 (1) ◽  
pp. 99-101
Author(s):  
Mohammad Shahriar ◽  
Mahboob Hossain ◽  
Shaila Kabir
Keyword(s):  
Escherichia Coli ◽  
Nalidixic Acid ◽  
E Coli ◽  
Antimicrobial Sensitivity ◽  
Sensitivity Pattern ◽  
Low Sensitivity ◽  
Academy Of Sciences ◽  
Higher Sensitivity

A study of antimicrobial sensitivity of Escherichia coli (E. coli) isolated from clinical sourcesof different diagnostic centers of Dhaka, Bangladesh was carried out to facilitate the choice of drugin the management of E. coli induced symptoms. Very low sensitivity of E. coli towards ampicillin(4%), aztreonam (4%), cloxacillin (5%), nalidixic acid (5%), ciprofloxacin (7.5%), ceftriaxone(12.5%), doxycycline (12.5%), ceftazidime (16.25%), co-trimoxazole (20%), chloramphenicol(22.51%), tetracycline (25%), and netilmicin (35%) was observed. Higher sensitivity pattern wasobserved for gentamicin (56%) and only imipenem (95%) showed sensitivity pattern possiblysusceptible enough to consider for the management of E. coli induced cases in the area under study.The low sensitivity to different antimicrobial could be attributed to their prevailing usage and abusein the area under study.Key words: E. coli; Antimicrobial sensitivity; Clinical isolatesDOI: 10.3329/jbas.v34i1.5497Journal of Bangladesh Academy of Sciences, Vol.34, No.1, 99-101, 2010

Drug Resistance of Enterobacteriaceae Isolated from Chicken Carcasses

1997 ◽  
Vol 60 (8) ◽  
pp. 1001-1005 ◽  
Author(s):  
MARIA A. TESSI ◽  
MARIA S. SALSI ◽  
MARIA I. CAFFER ◽  
MARIA A. MOGUILEVSKY
Keyword(s):  
Nalidixic Acid ◽  
Processing Plant ◽  
Antibiotic Resistant ◽  
E Coli ◽  
Resistance Patterns ◽  
R Plasmids ◽  
Resistant Strains ◽  
Different Strains ◽  
K 12 ◽  
R Factors

The antibiotic resistance profiles and transferable R factors of Salmonella and Escherichia coli isolates from 104 broiler carcasses taken from one processing plant were determined. Carcasses were sampled after immersion chilling. All samples were transported iced and immediately analyzed upon arrival to the laboratory. The resistance patterns of isolates to 12 antibiotics were determined (i.e., ampicillin, cephalothin, streptomycin, sulfisoxazole, trim-ethoprim-sulfamethoxazole, nalidixic acid, tetracycline, neomycin, chloramphenicol, gentamicin, colistin, and nitrofurantoin). Isolates resistant to one or more antibiotics were utilized as donors of resistance to completely antibiotic-sensitive strains, an E. coli K-12, F−, J5, azide-resistant strain and a Salmonella serovar Enteritidis. Transfer of the different R plasmids was confirmed by the determination of the resistance patterns of the transconjugants. Of the 93 Salmonella and 71 E. coli strains isolated from these samples, the largest numbers were resistant to tetracycline (52.7% and 49.3%), sulfisoxazole (45.2% and 42.3%), and streptomycin (37.6% and 39.4%). Large percentages of the Salmonella (33.3%) and the E. coli (30.0%) strains transferred all or part of their resistance to E. coli K-12 in mixed cultures. Great variation was observed between different strains in the frequency at which they transferred resistance. Resistance to tetracycline, sulfisoxazole, and streptomycin was found to be conferred by 31.7%, 29.8%, and 21.6% of the 19 R factors identified. No transfer of resistance to nalidixic acid, gentamicin, cephalothin, nitrofurantoin, and chloramphenicol was detected. When 30 antibiotic-resistant E. coli strains were cultured with a sensitive strain of Salmonella serovar Enteritidis,7 (23.3%) of the resistant strains were found capable of transferring R factors. Only 2 (6.7%) of the resistant strains could transfer R factors and unusual β-galactosidase activity.

scholarly journals Antimicrobial use policy change in pre-weaned dairy calves and its impact on antimicrobial resistance in commensal Escherichia coli: a cross sectional and ecological study

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Josephine A. Afema ◽  
Margaret A. Davis ◽  
William M. Sischo
Keyword(s):  
Escherichia Coli ◽  
Nalidixic Acid ◽  
Latent Class ◽  
Farm Management ◽  
Antimicrobial Use ◽  
Policy Changes ◽  
Cross Sectional ◽  
Calf Health ◽  
E Coli ◽  
Resistance Patterns

Abstract Background This study is based on data collected to investigate the relation of peri-parturient events (colostrum quality, passive transfer of immunity, calving difficulty) on calf health and antimicrobial use. A component of the study was to provide feedback to farm management to identify calves at risk for disease and promote antimicrobial stewardship. At the start of the study (May 2016), a combination of enrofloxacin, penicillin, and sulfamethoxazole was the first treatment given to clinically abnormal calves. Based on feedback and interaction between study investigators, farm management and consulting veterinarians, a new policy was implemented to reduce antimicrobial use in calves. In August, the first treatment was changed to a combination of ampicillin and sulfamethoxazole. In September, the first treatment was reduced to only sulfamethoxazole. We investigated the effects of these policy changes in antimicrobial use on resistance in commensal Escherichia coli. Results We enrolled 4301 calves at birth and documented antimicrobial use until weaning. Most calves (99.4%) received antimicrobials and 70.4% received a total of 2–4 treatments. Antimicrobial use was more intense in younger calves (≤ 28 days) relative to older calves. We isolated 544 E. coli from fecal samples obtained from 132 calves. We determined resistance to 12 antimicrobials and 85% of the isolates were resistant to at least 3 antimicrobial classes. We performed latent class analysis to identify underlying unique classes where isolates shared resistance patterns and selected a solution with 4 classes. The least resistant class had isolates that were mainly resistant to only tetracycline and sulfisoxazole. The other 3 classes comprised isolates with resistance to ampicillin, chloramphenicol, aminoglycosides, sulfonamides, tetracycline, in addition to either ceftiofur; or nalidixic acid; or ciprofloxacin plus nalidixic acid and ceftiofur. Overall, E coli from younger calves and calves that received multiple treatments were more likely to have extensive resistance including resistance to fluoroquinolones and ceftiofur. In general, there was a declining trend in resistance to most antimicrobials during and after policy changes were implemented, except for ampicillin, ciprofloxacin, ceftiofur and gentamicin. Conclusions Information feedback to farms can influence farm managers to reduce antimicrobial use and this can change endemic farm resistance patterns.

Characterization and antibiogram of enteropathogenic Escherichia coli isolated from diarrhoeic and non-diarrhoeic dogs in South Bengal, India

2015 ◽  
Author(s):  
A. Banik ◽  
D. P. Isore ◽  
S. N. Joardar ◽  
K. Batabyal ◽  
S. Dey
Keyword(s):  
Escherichia Coli ◽  
Nalidixic Acid ◽  
West Bengal ◽  
Sheep Blood Agar ◽  
Blood Agar ◽  
Enteropathogenic Escherichia Coli ◽  
Highly Pathogenic ◽  
E Coli ◽  
Sheep Blood ◽  
Common Serotypes

Diarrhoea in canines is mainly caused by Escherichia coli which can be fatal also. To understand the depth of this infection, a study was undertaken to detect E. coli isolates from diarrhoeic and non-diarrhoeic dogs in Southern part of West Bengal. A total of 112 canine samples were tested during May to September 2012 revealing approx 63.4% (71) samples positive for Escherichia coli. The most common serotypes were O8 (23.9%) followed by O157 (19.7%), O101 (16.9%), O26 (15.5%), O153 (12.7%) and O6 (11.3%). Among these O6, O8, O26 and O157 were highly pathogenic to mice causing almost 100% mortality within 24hrs of inoculation and were also detected to be haemolytic on sheep blood agar plates except serotype O8. These isolates were mostly sensitive to nalidixic acid (80.29%), cotrimoxazole (78.88%), ciprofloxacin (74.65%), colistin and ceftriaxone (both 71.83%) but were resistant to amikacin (97.18%), kanamycin (95.78%), cephalexin (92.96%) and enrofloxacin (84.51%).

scholarly journals The incidence of antibiotic resistance and other characteristics amongst Escherichia coli strains causing fatal infection in chickens: the utilization of these characteristics to study the epidemiology of the infection

1973 ◽  
Vol 71 (4) ◽  
pp. 771-781 ◽  
Author(s):  
E. D. Heller ◽  
H. Williams Smith
Keyword(s):  
Escherichia Coli ◽  
Antibiotic Resistance ◽  
Nalidixic Acid ◽  
Broiler Chickens ◽  
Transfer Factors ◽  
E Coli ◽  
Fatal Infection

SummaryOf 173 epidemiologically unrelated strains of Escherichia coli isolated from the pericardial sac of chickens that had died from infection with these organisms in England in 1972, approximately 1 year after the introduction of legislation forbidding the routine use of feeds containing ‘therapeutic’ antibiotics, 83·8% were resistant to sulphonamides, 31·2 % to tetracyclines, 20·8% to furazolidone, 18·5% to streptomycin, 2·9% to spectinomycin and 1·2% to ampicillin; none of the strains were resistant to chloramphenicol, neomycin, polymixin, trimethoprim or nalidixic acid. The sulphonamide resistance and possibly some of the resistance to other agents might have been the consequence of sulphonamides being exempted from the legislation. Much of the resistance, with the exception of that to furazolidone, was of the transferable type. Many strains possessed transfer factors in the absence of any known transferable characteristic. Colicine production was twice as common in the pathogenic strains as in a collection of strains isolated from the faeces of healthy chickens; about half of it was transferable.By means of serology, antibiotic resistance and other markers, it was found that several different kinds of E. coli were usually incriminated in any one outbreak of E. coli infection in broiler chickens. Sometimes the same kinds of E. coli were found in outbreaks in consecutive crops of chickens on the same farm. New kinds, too, appeared to be brought in by replacement chickens.

scholarly journals Effect of Forage or Grain Diets with or without Monensin on Ruminal Persistence and Fecal Escherichia coli O157:H7 in Cattle

2004 ◽  
Vol 70 (9) ◽  
pp. 5336-5342 ◽  
Author(s):  
M. J. Van Baale ◽  
J. M. Sargeant ◽  
D. P. Gnad ◽  
B. M. DeBey ◽  
K. F. Lechtenberg ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Nalidixic Acid ◽  
Escherichia Coli O157 ◽  
Fecal Samples ◽  
Fecal Shedding ◽  
E Coli ◽  
Culture Positive ◽  
Forage Diets

ABSTRACT Twelve ruminally cannulated cattle, adapted to forage or grain diet with or without monensin, were used to investigate the effects of diet and monensin on concentration and duration of ruminal persistence and fecal shedding of E. coli O157:H7. Cattle were ruminally inoculated with a strain of E. coli O157:H7 (1010 CFU/animal) made resistant to nalidixic acid (Nalr). Ruminal and fecal samples were collected for 11 weeks, and then cattle were euthanized and necropsied and digesta from different gut locations were collected. Samples were cultured for detection and enumeration of Nalr E. coli O157:H7. Cattle fed forage diets were culture positive for E. coli O157:H7 in the feces for longer duration (P < 0.05) than cattle fed a grain diet. In forage-fed cattle, the duration they remained culture positive for E. coli O157:H7 was shorter (P < 0.05) when the diet included monensin. Generally, ruminal persistence of Nalr E. coli O157:H7 was not affected by diet or monensin. At necropsy, E. coli O157:H7 was detected in cecal and colonic digesta but not from the rumen. Our study showed that cattle fed a forage diet were culture positive longer and with higher numbers than cattle on a grain diet. Monensin supplementation decreased the duration of shedding with forage diet, and the cecum and colon were culture positive for E. coli O157:H7 more often than the rumen of cattle.

Comparative Examination of Escherichia coli O157:H7 Survival on Romaine Lettuce and in Soil at Two Independent Experimental Sites

2012 ◽  
Vol 75 (3) ◽  
pp. 480-487 ◽  
Author(s):  
GREG BEZANSON ◽  
PASCAL DELAQUIS ◽  
SUSAN BACH ◽  
ROBIN McKELLAR ◽  
ED TOPP ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Nalidixic Acid ◽  
Abiotic Factors ◽  
Decay Rates ◽  
Escherichia Coli O157 ◽  
Production Environment ◽  
Romaine Lettuce ◽  
Ecological Fitness ◽  
E Coli ◽  
Significant Difference

Little is known about the influence of abiotic factors such as climate and soil chemistry on the survival of Escherichia coli O157:H7 in field lettuce. We applied a nalidixic acid–resistant derivative of strain ATCC 700728 to field-grown romaine lettuce in two regions in Canada characterized by large variances in soil type and climate. Surviving populations in soil and on lettuce leaves were estimated on sorbitol MacConkey agar supplemented with nalidixic acid. Data were fitted with the Weibull decline function to permit comparison of decay rates in the two experimental sites. E. coli O157:H7 populations fell from 105 to &lt;102 CFU/g on leaves, and &lt;103 CFU/g in soil within 7 days after inoculation. Analysis revealed there was no significant difference between decay rates at the two experimental sites in either environment. The results of this study suggest that the inherent ecological fitness of E. coli O157:H7 ATCC 700728 determines the extent of survival in the production environment.

scholarly journals Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams

2007 ◽  
Vol 1 (03) ◽  
pp. 257-262 ◽  
Author(s):  
Samuel Kariuki ◽  
Gunturu Revathi ◽  
John Corkill ◽  
John Kiiru ◽  
Joyce Mwituria ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Urinary Tract ◽  
Nalidixic Acid ◽  
Urinary Tract Infections ◽  
Acid Resistance ◽  
Beta Lactam ◽  
E Coli ◽  
Extended Spectrum ◽  
Tract Infections ◽  
Multiple Drugs

Background: Uropathogenic Escherichia coli are increasingly becoming resistant to flouroquinolones and to other commonly available antimicrobials. We sought to investigate the genetic basis for fluoroquinolone and extended spectrum beta-lactam (ESBL) resistance in 17 fluoroquinolone-resistant (MIC of levofloxacin and ciprofloxacin >32 μg/ml) E. coli isolated from patients with urinary tract infections (UTIs). Methods: We applied PCR and Pulsed Field Gel Electrophoresis (PFGE) to characterize resistance genes and to determine clonal relatedness of strains, respectively. Results: Twelve of the 17 E. coli were resistant to multiple drugs, including ampicillin, co-amoxyclav, cefotaxime, ceftriaxone, ceftazidime and gentamicin and nalidixic acid and produced plasmid-mediated CTX-M-15 type ESBLs and CMY-2 AmpC type enzymes. The other 5 E. coli that were non-ESBL-producing were multiply resistant to ampicillin, nitrofurantoin, cefoxitin, nalidixic acid. Resistance to fluoroquinolones resulted from a combination of the presence of qnrA, qnrB, ciprofloxacin acetylating enzyme designated aac(6’)-1b-cr, and mutations in the two amino acid substitutions; 83 Serine (TCG) to Leucine (TTG) and 87 Aspartic acid (GAC) to Asparagine (AAC). Conclusion: Antibiogram patterns and PFGE of E. coli showed that these were community acquired UTI caused by pockets of clonally-related and some discreet strain types. Plasmid-mediated CTX-M-15 beta-lactamases and CMY-2 AmpC enzymes and fluoroquinolone resistant E. coli are becoming increasingly prevalent in hospitals in Kenya, posing a major challenge in the management of UTIs.

Sign in / Sign up

Export Citation Format

Share Document